Related Experiment Video
Updated: Jul 28, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Regulating the neoplastic phenotype using engineered transcriptional repressors
W J Fredericks1, K Ayyanathan, F J Rauscher
1The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
Abstract:
We have applied engineered transcriptional repressors to specifically inhibit disease gene-activated pathways in oncogenesis. We have demonstrated that synthetic repressors combining PAX3 DNA binding domains with different repression domains, KRAB or SNAG, are able to specifically inhibit malignant growth and suppress tumorigenesis in alveolar rhabdomyosarcoma tumor cells transformed by the translocation-derived chimeric transcriptional activator, PAX3-FKHR. We discuss the potential applications of the engineered repressor strategy that relate to target gene analysis, mechanisms of repression, cell regulation, and possible anti-viral and cancer therapy.
Insights
Engineered repressors targeting disease genes show promise in halting cancer growth. This strategy effectively suppresses tumor formation in specific cancer cells, offering potential therapeutic applications.
Area of Science:
- Molecular biology
- Genetics
- Cancer research
Background:
- Oncogenesis involves disease gene-activated pathways.
- Targeting these pathways is crucial for cancer therapy.
- Chimeric transcriptional activators like PAX3-FKHR drive specific cancers.
Purpose of the Study:
- To apply engineered transcriptional repressors to inhibit oncogenic pathways.
- To evaluate the efficacy of synthetic repressors in suppressing malignant growth.
- To explore potential therapeutic applications of this gene repression strategy.
Main Methods:
- Engineered synthetic repressors were designed, combining PAX3 DNA binding domains with KRAB or SNAG repression domains.
- These repressors were applied to alveolar rhabdomyosarcoma tumor cells.
- The effect on malignant growth and tumorigenesis was assessed.
Main Results:
- Synthetic repressors specifically inhibited disease gene-activated pathways.
- The engineered repressors suppressed malignant growth in tumor cells.
- Tumorigenesis was suppressed in alveolar rhabdomyosarcoma cells transformed by PAX3-FKHR.
Conclusions:
- Engineered repressors offer a targeted approach to inhibit oncogenesis.
- This strategy demonstrates potential for cancer therapy by suppressing tumor growth.
- Further applications include target gene analysis, understanding repression mechanisms, and cell regulation.
Related Concept Videos
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Epigenetic Regulation
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...

